Refeyn

Game-Changing Gene-Therapy Tool: Detects Full Capsids Affordable for Small Biotechs

🧪 A benchtop gene-therapy tool now works in commercial-scale manufacturing, detecting DNA-filled viral capsids using light scattering. 💡 It distinguishes between empty and full capsids, and at $175k, it's accessible to smaller biotechs. 🔬 Added GMP compliance and capsid titer measurement capabilities.